About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Dr. Andelo Beletic, he is a lead researcher at Genos Ltd in Zagreb, a global leader in glycomics, and serves as an Assistant Editor for Biochemia Medica, the official journal of the Croatian Society of Medical Biochemistry and Laboratory Medicine.
Abstract: IgG antibodies are the most abundant antibody isotype in circulation and play key roles in numerous humoral immune processes. As glycoproteins, they carry complex carbohydrates, termed glycans, covalently attached to the protein backbone in the enzymatic process known as glycosylation, ongoing during IgG synthesis and maturation in the endoplasmic reticulum and Golgi apparatus. The composition of IgG glycome influences antibody stability, conformation, half-life, and effector functions, including antigen neutralization, opsonization, antibody-dependent cell-mediated (ADC) cytotoxicity, and ADC phagocytosis, as well as complement-dependent cytotoxicity.
Host: Dr. Joaquin Seras Franzoso, Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT). Vall d'Hebron Institut de Recerca (VHIR) -Vall d’Hebron Barcelona Hospital Campus.
Online assistance: https://gencat.zoom.us/j/82041153684
